Tally Health

Tally Health

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.tallyhealth.com

Last Round

Seed

Apr 6, 2023

Total Funding Raised

$10M

Company Overview

Tally Health is a consumer biotechnology company that aims to change the way people age by providing tools to improve healthspan and extend longevity. Co-founded by longevity expert Dr. David Sinclair and entrepreneur Whitney Casey, the company offers a membership-based platform that includes a proprietary at-home epigenetic test (TallyAge™) to determine a user's biological age via a cheek swab. Based on the test results and a lifestyle survey, Tally Health provides personalized, science-backed recommendations for diet, fitness, sleep, and mental health, along with its own line of longevity supplements. The company launched in February 2023 and was incubated by L Catterton. In April 2023, it announced a $10 million seed funding round led by Forerunner Ventures.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Subscription Commerce, Healthcare Analytics, Precision Medicine

Business Model

B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

at-home epigenetic biological age testlongevity subscription servicedirect-to-consumer longevity platformcellular aging measurementproprietary epigenetic aging clockhealthspan improvement platformlongevity dietary supplementscheek swab epigenetic testpersonalized digital lifestyle recommendationsconsumer wellness membership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tally Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tally Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 6, 2023

Key People

Founding team and executive leadership

Garret Ma

COO

Executive Team

Tally Health Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2026

    Acquired by Infinite Epigenetics, Inc. to create integrated health platform.

  • Sep 10, 2025

    New collaboration to determine medical necessity for supplements.

Tally Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tally Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tally Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range14
Year Founded2021
Last FundingApr 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.